← Leaderboards
Natalia B Ivanova
Yale University
$6,115,437
Attributed
$6,433,141
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,433,141 · 5
By mechanism
R01$6,017,891 · 4
R21$415,250 · 1
Top collaborators
- Smita Krishnaswamy1 shared
Most similar at Yale University
Same institution · by research overlap
- David M Miller$12,500,264
- Smita Krishnaswamy$4,708,472
- Ashley Abel$83,460
- Antonio Giraldez$24,949,135
- Jamy C. Peng$3,495,407
Others in their field
Top investigators on “Innovation”
- David R. Weir · University Of Michigan At Ann Arbor$382,307,654
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$319,874,172
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$311,654,401
- Richard A Gibbs · Baylor College Of Medicine$300,634,418
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$271,752,220
Research focus
InnovationMolecularGenesBurden Of IllnessCellsMapsMissionDisabilityStem CellsBaseMaintenanceComplexEpigenetic ProcessSelf-RenewalAffectHuman Embryonic Stem CellCell TypeRegulationAlzheimer&AposHuman DiseaseParkinson DiseaseChromatinPublic HealthNovel Strategies
Grant awards (21)
Uncovering the dynamics and regulatory logic of cell fate specification in cerebral organoid data$635,408
R01 · FY2025 · NS
Metabolic control of human endothelial development via the COUP-TF/1-deoxysphingosine axis$568,115
R01 · FY2025 · HL · contact PI
Metabolic control of human endothelial development via the COUP-TF/1-deoxysphingosine axis$584,578
R01 · FY2024 · HL · contact PI
Molecular control of pluripotency in humans$317,100
R01 · FY2022 · GM · contact PI
Molecular control of pluripotency in humans$59,237
R01 · FY2022 · GM · contact PI
Molecular control of pluripotent in humans - Cain Diversity Supplement$19,745
R01 · FY2022 · GM · contact PI
Molecular control of pluripotency in humans$317,100
R01 · FY2021 · GM · contact PI
Molecular control of pluripotency in humans$317,100
R01 · FY2020 · GM · contact PI
Derivation and characterization of induced trophoblast stem cells$188,750
R21 · FY2020 · HD · contact PI
Molecular control of pluripotency in humans$317,100
R01 · FY2019 · GM · contact PI
Derivation and characterization of induced trophoblast stem cells$226,500
R21 · FY2019 · HD · contact PI
Epigenetic control of the pluripotent state by chromatin-associated factor Dppa2$270,931
R01 · FY2018 · GM · contact PI
Epigenetic control of the pluripotent state by chromatin-associated factor Dppa2$30,725
R01 · FY2018 · GM · contact PI
Epigenetic control of the pluripotent state by chromatin-associated factor Dppa2$328,838
R01 · FY2017 · GM · contact PI
Novel differentiation repressor module in human ES cells$316,350
R01 · FY2017 · GM · contact PI
Epigenetic control of the pluripotent state by chromatin-associated factor Dppa2$328,838
R01 · FY2016 · GM · contact PI
Novel differentiation repressor module in human ES cells$316,350
R01 · FY2016 · GM · contact PI
Epigenetic control of the pluripotent state by chromatin-associated factor Dppa2$328,838
R01 · FY2015 · GM · contact PI
Novel differentiation repressor module in human ES cells$316,350
R01 · FY2015 · GM · contact PI
Epigenetic control of the pluripotent state by chromatin-associated factor Dppa2$328,838
R01 · FY2014 · GM · contact PI
Novel differentiation repressor module in human ES cells$316,350
R01 · FY2014 · GM · contact PI